These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 23583914)

  • 1. Crystal structure of the Cmr2-Cmr3 subcomplex in the CRISPR-Cas RNA silencing effector complex.
    Osawa T; Inanaga H; Numata T
    J Mol Biol; 2013 Oct; 425(20):3811-23. PubMed ID: 23583914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of the CRISPR-Cas RNA silencing Cmr complex bound to a target analog.
    Osawa T; Inanaga H; Sato C; Numata T
    Mol Cell; 2015 May; 58(3):418-30. PubMed ID: 25921071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of the Csm3-Csm4 subcomplex in the type III-A CRISPR-Cas interference complex.
    Numata T; Inanaga H; Sato C; Osawa T
    J Mol Biol; 2015 Jan; 427(2):259-73. PubMed ID: 25451598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target RNA capture and cleavage by the Cmr type III-B CRISPR-Cas effector complex.
    Hale CR; Cocozaki A; Li H; Terns RM; Terns MP
    Genes Dev; 2014 Nov; 28(21):2432-43. PubMed ID: 25367038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of an RNA silencing complex of the CRISPR-Cas immune system.
    Spilman M; Cocozaki A; Hale C; Shao Y; Ramia N; Terns R; Terns M; Li H; Stagg S
    Mol Cell; 2013 Oct; 52(1):146-52. PubMed ID: 24119404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystallization and preliminary X-ray diffraction analysis of the Cmr2-Cmr3 subcomplex in the CRISPR-Cas RNA-silencing effector complex.
    Osawa T; Inanaga H; Numata T
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2013 May; 69(Pt 5):585-7. PubMed ID: 23695584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of the Cmr2-Cmr3 subcomplex of the Cmr RNA silencing complex.
    Shao Y; Cocozaki AI; Ramia NF; Terns RM; Terns MP; Li H
    Structure; 2013 Mar; 21(3):376-84. PubMed ID: 23395183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of Cmr2 suggests a nucleotide cyclase-related enzyme in type III CRISPR-Cas systems.
    Zhu X; Ye K
    FEBS Lett; 2012 Mar; 586(6):939-45. PubMed ID: 22449983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conservation and variability in the structure and function of the Cas5d endoribonuclease in the CRISPR-mediated microbial immune system.
    Koo Y; Ka D; Kim EJ; Suh N; Bae E
    J Mol Biol; 2013 Oct; 425(20):3799-810. PubMed ID: 23500492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystallization and preliminary X-ray diffraction analysis of the CRISPR-Cas RNA-silencing Cmr complex.
    Osawa T; Inanaga H; Numata T
    Acta Crystallogr F Struct Biol Commun; 2015 Jun; 71(Pt 6):735-40. PubMed ID: 26057804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cmr4 is the slicer in the RNA-targeting Cmr CRISPR complex.
    Zhu X; Ye K
    Nucleic Acids Res; 2015 Jan; 43(2):1257-67. PubMed ID: 25541196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three CRISPR-Cas immune effector complexes coexist in Pyrococcus furiosus.
    Majumdar S; Zhao P; Pfister NT; Compton M; Olson S; Glover CV; Wells L; Graveley BR; Terns RM; Terns MP
    RNA; 2015 Jun; 21(6):1147-58. PubMed ID: 25904135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutting it close: CRISPR-associated endoribonuclease structure and function.
    Hochstrasser ML; Doudna JA
    Trends Biochem Sci; 2015 Jan; 40(1):58-66. PubMed ID: 25468820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure and CRISPR RNA-binding site of the Cmr1 subunit of the Cmr interference complex.
    Sun J; Jeon JH; Shin M; Shin HC; Oh BH; Kim JS
    Acta Crystallogr D Biol Crystallogr; 2014 Feb; 70(Pt 2):535-43. PubMed ID: 24531487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hot and crispy: CRISPR-Cas systems in the hyperthermophile Sulfolobus solfataricus.
    Zhang J; White MF
    Biochem Soc Trans; 2013 Dec; 41(6):1422-6. PubMed ID: 24256231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structures of the Cmr-β Complex Reveal the Regulation of the Immunity Mechanism of Type III-B CRISPR-Cas.
    Sofos N; Feng M; Stella S; Pape T; Fuglsang A; Lin J; Huang Q; Li Y; She Q; Montoya G
    Mol Cell; 2020 Sep; 79(5):741-757.e7. PubMed ID: 32730741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal Structures of Csm2 and Csm3 in the Type III-A CRISPR-Cas Effector Complex.
    Takeshita D; Sato M; Inanaga H; Numata T
    J Mol Biol; 2019 Feb; 431(4):748-763. PubMed ID: 30639408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural analyses of the CRISPR protein Csc2 reveal the RNA-binding interface of the type I-D Cas7 family.
    Hrle A; Maier LK; Sharma K; Ebert J; Basquin C; Urlaub H; Marchfelder A; Conti E
    RNA Biol; 2014; 11(8):1072-82. PubMed ID: 25483036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR RNA and anti-CRISPR protein binding to the
    Hong S; Ka D; Yoon SJ; Suh N; Jeong M; Suh JY; Bae E
    J Biol Chem; 2018 Feb; 293(8):2744-2754. PubMed ID: 29348170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CRISPR-associated Csx1 protein of Pyrococcus furiosus is an adenosine-specific endoribonuclease.
    Sheppard NF; Glover CV; Terns RM; Terns MP
    RNA; 2016 Feb; 22(2):216-24. PubMed ID: 26647461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.